Oct 2 (Reuters) - U.S. drugmaker Eli Lilly (LLY.N), opens new tab said on Wednesday it will invest $4.5 billion to create a new center in Indiana that will focus on developing new ways to ...

Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility ...

Oct 2 (Reuters) - The U.S. Food and Drug Administration removed Eli Lilly's (LLY.N), opens new tab blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely ...

He's a tireless researcher, expert deal hunter and excellent trivia partner. Lily Pulitzer (3) Hundreds of Lilly Pulitzer dresses are at some of their lowest prices of the year — but you’ve ...

LEBANON, Ind. – Eli Lilly and Company will invest an additional $4.5 billion in Boone County to create a new center for advanced manufacturing and drug development. The Lilly Medicine Foundry ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the company widen its share of the booming weight-loss drug market.

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have ...

As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of powerhouse rival Johnson & Johnson largely thanks to its diabetes and ...

(This story was updated to add new information.)Eli Lilly and Co. is investing an additional $4.5 billion into the LEAP Research and Innovation District in Lebanon, bringing the drug company's ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in ...